Post-approval studies (Phase 4)Study completedNCT03183908What this trial is testingFLUAD® vs. Fluzone® High-Dose StudyWho this might be right forPainQuality of LifeInjection Site Reaction+2 more Duke University 757
Post-approval studies (Phase 4)Study completedNCT05050318What this trial is testingAnnual Study for Collection of Serum Samples in Children and Older Adults Receiving the 2021-2022 Formulations of Fluzone Quadrivalent Vaccine and Fluzone High-Dose Quadrivalent Vaccine, RespectivelyWho this might be right forInfluenza ImmunizationHealthy Volunteers Sanofi Pasteur, a Sanofi Company 90
Early research (Phase 1)Study completedNCT04451954What this trial is testingStudy of Recombinant Influenza Vaccine Containing Different H3 Antigens Without or With Adjuvant in Healthy Adult SubjectsWho this might be right forInfluenza ImmunisationHealthy Volunteers Sanofi Pasteur, a Sanofi Company 210
Post-approval studies (Phase 4)Study completedNCT03982069What this trial is testingImmunologic Response to FluMist vs. FlucelvaxWho this might be right forInfluenza, HumanImmune Response Richard Zimmerman MD 465
Not applicableEnded earlyNCT02213432What this trial is testingInfluenza Vaccination in Cancer PatientsWho this might be right forCancer Seoul National University Hospital 97
Large-scale testing (Phase 3)Study completedNCT05062759What this trial is testingStudy to Assess the Effect of Tezepelumab on the Immune Response to Influenza Vaccination in Participants With AsthmaWho this might be right forModerate to Severe Asthma AstraZeneca 70
Testing effectiveness (Phase 2)Study completedNCT05422326What this trial is testingEvaluate Safety and Immunogenicity of One or Two Booster Vaccinations With H5N6 Influenza Vaccine in Adults Primed With H5N1 Influenza Vaccine or UnprimedWho this might be right forInfluenza, HumanInfluenza in BirdsRespiratory Tract Infections+5 more Seqirus 260
Not applicableStudy completedNCT01761734What this trial is testingPilot Text Message for Influenza VaccinationWho this might be right forInfluenza Columbia University 1,000
Testing effectiveness (Phase 2)Study completedNCT01393951What this trial is testingEvaluate the Immune Response to the ASP7374 and Its Safety in Healthy Adult VolunteersWho this might be right forHealthyImmunogenicity of ASP7374 UMN Pharma Inc. 165
Testing effectiveness (Phase 2)Study completedNCT00695669What this trial is testingA Trial to Test the Response to Different Vaccination Regimens With an H5N1 Vaccine With AS03 in Adults Aged 18-64Who this might be right forInfluenza GlaxoSmithKline 312
Testing effectiveness (Phase 2)Study completedNCT06361875What this trial is testingInvestigate the Safety and Immunogenicity of the Quadrivalent Influenza mRNA Vaccines in Adults Aged 18 Years and AboveWho this might be right forInfluenza ImmunizationHealthy Volunteers Sanofi Pasteur, a Sanofi Company 908
Post-approval studies (Phase 4)Looking for participantsNCT05108818What this trial is testingCharacterization of Humoral and Cellular Immune Responses Elicited by Influenza Vaccination in Healthy AdultsWho this might be right forInfluenza, Human University of Pennsylvania 700
Post-approval studies (Phase 4)Looking for participantsNCT05616546What this trial is testingBone Marrow and Peripheral Blood Immune Responses StudyWho this might be right forInfluenza Emory University 90
Testing effectiveness (Phase 2)Study completedNCT00680069What this trial is testingH5N1 (Clade 2) Vaccination of Adults and ElderlyWho this might be right forInfluenza National Institute of Allergy and Infectious Diseases (NIAID) 517
Not applicableStudy completedNCT01852656What this trial is testingEffectiveness of Influenza Vaccine Reminder SystemsWho this might be right forAsthmaChronic Obstructive Pulmonary Disease Kaiser Permanente 12,255
Early research (Phase 1)Study completedNCT03472976What this trial is testingH5N1 With or Without Topical Aldara in Healthy AdultsWho this might be right forAvian InfluenzaInfluenza Immunisation National Institute of Allergy and Infectious Diseases (NIAID) 50
Large-scale testing (Phase 3)Study completedNCT00310804What this trial is testingSafety and Immunogenicity of 3 Lots of Cell-derived Subunit Influenza Vaccine as Compared to 1 Lot to Egg-derived Subunit Influenza Vaccine in Healthy Adults (>=18 to <=60)Who this might be right forInfluenza Novartis Vaccines 1,200
Not applicableStudy completedNCT01522248What this trial is testingEarly Immune Responses to Inactivated Influenza Vaccine: a Pilot StudyWho this might be right forInfluenza Virus Vaccine Johns Hopkins Bloomberg School of Public Health 20
Testing effectiveness (Phase 2)Study completedNCT05553301What this trial is testingSafety and Immunogenicity of Quadrivalent Influenza mRNA Vaccine MRT5407 in Adult Participants18 Years of Age and OlderWho this might be right forInfluenza Immunization Sanofi Pasteur, a Sanofi Company 560
Large-scale testing (Phase 3)WithdrawnNCT04848467What this trial is testingCOVID-19: A Trial Studying the SARS-CoV-2 mRNA Vaccine CVnCoV to Learn About the Immune Response, the Safety, and the Degree of Typical Vaccination Reactions When CVnCoV is Given at the Same Time as a Flu Vaccine Compared to When the Vaccines Are Separately Given in Adults 60 Years of Age and OlderWho this might be right forSARS-CoV-2 InfectionCoronavirus Disease 2019 (COVID-19) Bayer